Los Angeles County Considering Flavored Tobacco Ban
Los Angeles County could become the largest jurisdiction in the U.S. to ban the sale of flavored tobacco products if a newly proposed ordinance...
FDA to Hold Workshop on Deemed Tobacco Product Applications
Mark your calendars–the U.S. Food and Drug Administration is holding a public meeting on deemed tobacco product applications. Scheduled for October 28-29, 2019, the...
FDA Proposed New Visual and Text Warning Labels for Cigarette Packaging and Ads
Cigarette packaging could see their biggest design change in the past 35 years if the U.S. Food and Drug Administration has its way. The...
FDA and FTC Issue Warning Letters Over Social Media Influencer Concerns
It's not uncommon in today's regulatory landscape to hear that the U.S. Food and Drug Administration (FDA) has sent a warning letter to a...
Premium Cigar Manufacturers File Joint FDA Comment on Regulations
Some of the largest premium cigar manufacturers have come together to file a comment with the U.S. Food and Drug Administration on the subject...
Cuomo Signs Legislation Raising Minimum Tobacco Purchasing Age to 21
New York's Gov. Andrew Cuomo continues to combat they perceived health threat posed by tobacco and e-cigarette products by signing legislation (S.2833/A.558) into law....
May 2020 Deadline Set for Substantial Equivalence Applications
A federal judge has given cigar and e-cigarette manufacturers 10-months to apply for approval from the U.S. Food and Drug Administration (FDA) to keep...
Cigar Trade Groups Fight to Keep Substantial Equivalence Extension
On July 2, 2019, the ongoing legal battle between the cigar industry and the U.S. Food and Drug Administration (FDA) reached a new level...
FDA Proposed 10-Month Deadline for E-Cigarette PMTA Applications
The deadline for e-cigarette manufacturers to submit their premarket tobacco applications (PMTA) to the U.S. Food and Drug Administration (FDA) will be coming sooner...
FDA Extends Commenting Period for Substantial Equivalence Draft Guidance
The U.S. Food and Drug Administration (FDA) has announced that it has extended the commenting period for the agency's draft guidance on Substantial Equivalence...
